The collaboration, called the Pharmacy Care Reimagined Initiative, aims to reduce prescription drug costs and improve transparency for the insurer’s 5 million health plan members.
The move follows Blue Shield’s decision to sever ties with CVS Health’s Caremark PBM, a change that caused stock prices of major PBMs to drop when it was announced in August 2023.
The new venture is expected to save Blue Shield up to $500 million annually in drug costs, executives involved told Forbes.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
